The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: A meta-analysis of current literature

Vaccine

Volumn 28, Issue 22, 2010, Pages 3773-3777

  Alavian, Seyed Moayed ^a   Tabatabaei, Seyed Vahid ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chronic kidney disease; Diabetes mellitus; HBV vaccine; Meta analysis

Indexed keywords

EUVAX; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOLOGICAL ADJUVANT; LEVAMISOLE; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIABETES MELLITUS; DRUG RESPONSE; HEMODIALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; INFORMATION RETRIEVAL; KIDNEY FAILURE; META ANALYSIS; PRIORITY JOURNAL; PUBLISHING; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VACCINATION;

CONFIDENCE INTERVALS; DIABETES COMPLICATIONS; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; KIDNEY FAILURE, CHRONIC; MODELS, STATISTICAL; ODDS RATIO;

EID: 77952322109     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.03.038     Document Type: Review

References (22)

1. Fabrizi F., Lunghi G., Poordad F.F., and Martin P. Novel perspectives on hepatitis B vaccine in dialysis population. Int J Artif Organs 25 March (3) (2002) 174-181
2. Sali S. HBV vaccination in chronic renal failure patients. Hepatitis Monthly 6 1 (2006) 25-29
3. Miller E.R., Alter M.J., and Tokars J.I. Protective effect of hepatitis B vaccine in chronic hemodialysis patients. Am J Kidney Dis 33 February (2) (1999) 356-360
4. Casciato D.A., McAdam L.P., Kopple J.D., Bluestone R., Goldberg L.S., Clements P.J., et al. Immunologic abnormalities in hemodialysis patients: improvement after pyridoxine therapy. Nephron 38 1 (1984) 9-16
5. Kurz P., Kohler H., Meuer S., Hutteroth T., and Meyer zum Buschenfelde K.H. Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. Kidney Int 29 June (6) (1986) 1209-1214
6. Vanholder R., Van Loo A., Dhondt A.M., De Smet R., and Ringoir S. Influence of uraemia and haemodialysis on host defence and infection. Nephrol Dial Transplant 11 April (4) (1996) 593-598
7. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 December (6865) (2001) 782-787
8. Ocak S., and Eskiocak A.F. The evaluation of immune responses to hepatitis B vaccination in diabetic and non-diabetic haemodialysis patients and the use of tetanus toxoid. Nephrology (Carlton) 13 March (6) (2008) 487-491
9. Taheri S., Shahidi S., Moghtaderi J., Seirafian S., Emami A., and Eftekhari S.M. Response rate to hepatitis B vaccination in patients with chronic renal failure and end-stage-renal-disease: influence of diabetes mellitus. J Res Med Sci 10 6 (2005) 384-390
10. Lacson E., Teng M., Ong J., Vienneau L., Ofsthun N., and Lazarus J.M. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease. Hemodial Int 9 October (4) (2005) 367-375
11. Chin A.I. Hepatitis B virus vaccine response in hemodialysis: baseline patient characteristics. Hemodial Int 7 (2003) 296-303
12. Liu Y.L., Kao M.T., and Huang C.C. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis. Vaccine 23 June (30) (2005) 3957-3960
13. DaRoza G., Loewen A., Djurdjev O., Love J., Kempston C., Burnett S., et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis 42 December (6) (2003) 1184-1192
14. Morais E.O., Resende M.R., Oliveira A.M., Sinkoc V.M., Garcia M.T., Angerami R.N., et al. Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up. Aliment Pharmacol Ther 25 April (7) (2007) 849-855
15. Waite N.M., Thomson L.G., and Goldstein M.B. Successful vaccination with intradermal hepatitis B vaccine in hemodialysis patients previously nonresponsive to intramuscular hepatitis B vaccine. J Am Soc Nephrol 5 May (11) (1995) 1930-1934
16. Pozzilli P., Arduini P., Visalli N., Sutherland J., Pezzella M., Galli C., et al. Reduced protection against hepatitis B virus following vaccination in patients with type 1 (insulin-dependent) diabetes. Diabetologia 30 October (10) (1987) 817-819
17. Alper C.A., Kruskall M.S., Marcus-Bagley D., Craven D.E., Katz A.J., Brink S.J., et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 321 September (11) (1989) 708-712
18. Geerlings S.E., and Hoepelman A.I. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 26 December (3-4) (1999) 259-265
19. Girndt M., Sester M., Sester U., Kaul H., and Kohler H. Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int 59 April (4) (2001) 1382-1389
20. Fabrizi F., Dixit V., Magnini M., Elli A., and Martin P. Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease. Aliment Pharmacol Ther 24 August (3) (2006) 497-506
21. Fabrizi F., Ganeshan S.V., Dixit V., and Martin P. Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease. Aliment Pharmacol Ther 24 September (5) (2006) 789-796
22. Alavian S.M., and Tabatabaei S.V. Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials. Clin Ther 32 January (1) (2010) 1-10